These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 16222656

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
    Christopher M, Rantzau C, Chen ZP, Snow R, Kemp B, Alford FP.
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats.
    Rossetti L, Giaccari A.
    J Clin Invest; 1990 Jun; 85(6):1785-92. PubMed ID: 2189891
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects.
    Abdul-Ghani MA, Matsuda M, DeFronzo RA.
    Diabet Med; 2008 Nov; 25(11):1289-94. PubMed ID: 19046218
    [Abstract] [Full Text] [Related]

  • 7. Determinants of glucose turnover in the pathophysiology of diabetes: an in vivo analysis in diabetic dogs.
    Fisher SJ, Lekas MC, McCall RH, Shi ZQ, Giacca A, Vranic M.
    Diabetes Metab; 1996 Apr; 22(2):111-21. PubMed ID: 8792091
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range.
    Jani R, Molina M, Matsuda M, Balas B, Chavez A, DeFronzo RA, Abdul-Ghani M.
    Diabetes Care; 2008 Feb; 31(2):311-5. PubMed ID: 18000182
    [Abstract] [Full Text] [Related]

  • 14. Isolated hepatic cholinergic denervation impairs glucose and glycogen metabolism.
    Xue C, Aspelund G, Sritharan KC, Wang JP, Slezak LA, Andersen DK.
    J Surg Res; 2000 May 01; 90(1):19-25. PubMed ID: 10781370
    [Abstract] [Full Text] [Related]

  • 15. Long-term physical training increases liver IGF-I in diabetic rats.
    Leme JA, Silveira RF, Gomes RJ, Moura RF, Sibuya CA, Mello MA, Luciano E.
    Growth Horm IGF Res; 2009 Jun 01; 19(3):262-6. PubMed ID: 19201234
    [Abstract] [Full Text] [Related]

  • 16. 18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study.
    Iozzo P, Gastaldelli A, Järvisalo MJ, Kiss J, Borra R, Buzzigoli E, Viljanen A, Naum G, Viljanen T, Oikonen V, Knuuti J, Savunen T, Salvadori PA, Ferrannini E, Nuutila P.
    J Nucl Med; 2006 Jun 01; 47(6):1016-22. PubMed ID: 16741312
    [Abstract] [Full Text] [Related]

  • 17. Intestinal glucose uptake in normal, untreated and insulin-treated diabetic dogs.
    Alada AR, Falokun PO, Oyebola DD.
    Afr J Med Med Sci; 2005 Jun 01; 34(2):147-56. PubMed ID: 16749339
    [Abstract] [Full Text] [Related]

  • 18. Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: normalization of glucose kinetics by short-term fasting.
    Féry F.
    J Clin Endocrinol Metab; 1994 Mar 01; 78(3):536-42. PubMed ID: 8126123
    [Abstract] [Full Text] [Related]

  • 19. Novel hepatoselective insulin analogues: studies with covalently linked thyroxyl-insulin complexes.
    Shojaee-Moradie F, Eckey H, Jackson NC, Schüttler A, Brandenburg D, Sönksen PH, Jones RH.
    Diabet Med; 1998 Nov 01; 15(11):928-36. PubMed ID: 9827847
    [Abstract] [Full Text] [Related]

  • 20. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
    Zinker B, Mika A, Nguyen P, Wilcox D, Ohman L, von Geldern TW, Opgenorth T, Jacobson P.
    Metabolism; 2007 Mar 01; 56(3):380-7. PubMed ID: 17292727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.